Restless Legs risk in the biracial East Baltimore cohort
东巴尔的摩混血儿群体的不安腿风险
基本信息
- 批准号:6956470
- 负责人:
- 金额:$ 6.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The major goal of this study is to determine the relationship of the Restless Legs Syndrome (RLS) to potential risk factors: ethnicity and both physical and mental health. Another goal is to explore the relationship of RLS to sleep and function/disability. The analysis will use the database accumulated since 1980 in the East Baltimore Cachment area study (EGA). Questions on diagnostic features of RLS are included within the current wave of EGA. Accumulated data includes information on the subjects' demographics, social and functional situation, physical and psychological health. About 1/3 of the subjects are African-American. Specific Aims: 1) To determine whether RLS has a different prevalence in the African-American and Caucasian populations. There is a strong clinical suspicion that RLS is less prevalent in African-American populations, but evidence is lacking. If ethnic differences are found, they may be related to other characteristics of the two populations. 2) To determine whether longitudinal health measures or laboratory values provide robust risk measures for development of RLS. Previous studies have indicated that both poor physical and mental health are related to RLS. The wealth of longitudinal measures in the EGA database provide the opportunity to examine RLS in relationship to lifetime histories of physical and mental disorders. Laboratory values for APO-E types and iron measures included in the database can provide direct links to biological variables. 3) To determine whether RLS symptoms contribute to the burden of sleep problems and function /disability in individuals. Information on these issues in the EGA database will exploration on whether RLS makes a significant contribution to these major public health problems. The value of these data analyses will be enhanced by the independent, blinded confirmation of the RLS screening questions (in approximately 20% of all subjects) using a validated diagnostic interview.
这项研究的主要目标是确定不宁腿综合症(RLS)与潜在风险因素的关系:种族以及身心健康。另一个目标是探索RLS与睡眠和功能/残疾的关系。分析将使用自1980年以来在东巴尔的摩地区研究(EGA)中积累的数据库。关于RLS诊断特征的问题包括在当前的EGA浪潮中。积累的数据包括受试者的人口统计信息、社会和功能状况以及身体和心理健康状况。约三分之一的受试者是非洲裔美国人。具体目标:1)确定RLS在非裔美国人和高加索人群中的患病率是否不同。临床上有强烈的怀疑,认为RLS在非裔美国人中不那么普遍,但缺乏证据。如果发现种族差异,可能与两个群体的其他特征有关。2)确定纵向健康措施或实验室数值是否为RLS的发展提供可靠的风险衡量标准。以前的研究表明,身体和精神健康状况不佳都与RLS有关。EGA数据库中丰富的纵向测量提供了检查RLS与身体和精神障碍终生病史的关系的机会。数据库中包括的APO-E类型和铁测量的实验室数值可以提供与生物变量的直接联系。3)确定RLS症状是否对个人的睡眠问题和功能/残疾造成负担。EGA数据库中关于这些问题的信息将探索RLS是否对这些重大公共卫生问题做出了重大贡献。这些数据分析的价值将通过使用有效的诊断性访谈对RLS筛查问题进行独立、盲目的确认(在所有受试者中约20%)来提高。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOCHANG B LEE其他文献
HOCHANG B LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOCHANG B LEE', 18)}}的其他基金
Intracranial Atherosclerosis and predictors of Post-CABG Depression
颅内动脉粥样硬化和 CABG 术后抑郁的预测因子
- 批准号:
8468742 - 财政年份:2010
- 资助金额:
$ 6.93万 - 项目类别:
Intracranial Atherosclerosis and predictors of Post-CABG Depression
颅内动脉粥样硬化和 CABG 术后抑郁的预测因子
- 批准号:
8251171 - 财政年份:2010
- 资助金额:
$ 6.93万 - 项目类别:
Intracranial Atherosclerosis and predictors of Post-CABG Depression
颅内动脉粥样硬化和 CABG 术后抑郁的预测因子
- 批准号:
8629790 - 财政年份:2010
- 资助金额:
$ 6.93万 - 项目类别:
Intracranial Atherosclerosis and predictors of Post-CABG Depression
颅内动脉粥样硬化和 CABG 术后抑郁的预测因子
- 批准号:
8100324 - 财政年份:2010
- 资助金额:
$ 6.93万 - 项目类别:
Intracranial Atherosclerosis and predictors of Post-CABG Depression
颅内动脉粥样硬化和 CABG 术后抑郁的预测因子
- 批准号:
7984829 - 财政年份:2010
- 资助金额:
$ 6.93万 - 项目类别:
Restless Legs risk in the biracial East Baltimore cohort
东巴尔的摩混血儿群体的不安腿风险
- 批准号:
7116920 - 财政年份:2005
- 资助金额:
$ 6.93万 - 项目类别:
Cognitive Sequelae of early and mid-life depression
早中年抑郁症的认知后遗症
- 批准号:
6774214 - 财政年份:2004
- 资助金额:
$ 6.93万 - 项目类别:
Cognitive Sequelae of early and mid-life depression
早中年抑郁症的认知后遗症
- 批准号:
6867440 - 财政年份:2004
- 资助金额:
$ 6.93万 - 项目类别:
Cognitive Sequelae of early and mid-life depression
早中年抑郁症的认知后遗症
- 批准号:
7037444 - 财政年份:2004
- 资助金额:
$ 6.93万 - 项目类别:
Cognitive Sequelae of early and mid-life depression
早中年抑郁症的认知后遗症
- 批准号:
7196487 - 财政年份:2004
- 资助金额:
$ 6.93万 - 项目类别:
相似海外基金
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
人类载脂蛋白 E 同工型在西尼罗河病毒暴露对阿尔茨海默病相关行为改变、认知损伤、神经炎症和神经病理学的长期影响中的作用
- 批准号:
10658408 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
A Therapeutic Role for Apolipoprotein-E in the Germ Theory of Alzheimer's Dementia
载脂蛋白-E 在阿尔茨海默氏痴呆病菌理论中的治疗作用
- 批准号:
10601779 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Investigating how apolipoprotein E genotypes modify fatty acid metabolism
研究载脂蛋白 E 基因型如何改变脂肪酸代谢
- 批准号:
RGPIN-2018-06116 - 财政年份:2022
- 资助金额:
$ 6.93万 - 项目类别:
Discovery Grants Program - Individual
Targeting apolipoprotein E for Alzheimer's disease therapy.
靶向载脂蛋白 E 治疗阿尔茨海默病。
- 批准号:
22K06460 - 财政年份:2022
- 资助金额:
$ 6.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10674878 - 财政年份:2022
- 资助金额:
$ 6.93万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 和阿尔茨海默病的免疫代谢
- 批准号:
10388528 - 财政年份:2022
- 资助金额:
$ 6.93万 - 项目类别:
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10515592 - 财政年份:2022
- 资助金额:
$ 6.93万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 与阿尔茨海默病的免疫代谢
- 批准号:
10644996 - 财政年份:2022
- 资助金额:
$ 6.93万 - 项目类别:
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis
载脂蛋白E糖基化及其在阿尔茨海默病发病机制中的作用
- 批准号:
10601040 - 财政年份:2021
- 资助金额:
$ 6.93万 - 项目类别:
Impact of cysteine modifications of apolipoprotein E on the remnant lipoprotein metabolism
载脂蛋白E半胱氨酸修饰对残余脂蛋白代谢的影响
- 批准号:
21K07310 - 财政年份:2021
- 资助金额:
$ 6.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)